MomentumIQ Navigation
Strategy Library
All Strategies Stock Screener
Learn & Research
Learning Center Calculators
Sign In Sign Up Free

Upgrade to Pro

Unlimited backtests · All signals · ₹399/month

Upgrade Now →

GLENMARK — Glenmark Pharmaceuticals Ltd.

Download Report (XLSX)
Quick Nav GLENMARK Overview ← Screener
GLENMARK · NSE
Glenmark Pharmaceuticals Ltd.
Healthcare NSE Equity Data: 02 Oct 2026
₹2,331.00
+₹0 (+0%)
52W High₹2,537.56
52W Low₹1,841.96
Avg Vol (20D)5.97L
RSI 1443.1
Vol Ratio1.63×
ATR 14₹76.67
5D Change-2.06%
📊 Analysis: GLENMARK closed at ₹2,331.00 today, up 0%. RSI at 43.1 — below midpoint, momentum is weak. Price is 4.1% above its 200-day EMA (₹2,239.29) — long-term trend is up. Volume was 1.63× the average — above-normal interest from market participants. Average daily range (ATR14) is ₹76.67 (3.3% of price) — useful for setting stop loss levels.
Price History — 365 trading days
Daily · NSE

Technical Conditions — 02 Oct 2026

Above EMA200
Price above 200-day EMA — long-term uptrend

Technical Indicators

Momentum
RSI (14)
43.1
Neutral
MACD
-7.9756
Signal: 8.7137
MACD Histogram
-16.6893
Bearish momentum
1D Change
+0%
5D Change
-2.06%
Volume Ratio
1.63×
Above average
Trend — EMA Levels
EMA 20
₹2,393.12
↓ Price below
EMA 50
₹2,366.34
↓ Price below
EMA 200
₹2,239.29
↑ Long-term uptrend
vs EMA 50
-1.49%
vs EMA 200
+4.1%
EMA Alignment
Bullish Stack
Volatility — Bollinger Bands
BB Upper
₹2,509.06
BB Mid (SMA20)
₹2,411.03
BB Lower
₹2,313.00
BB Width
0.0813
Normal width
ATR (14)
₹76.67
Daily range average
ATR % of Price
3.3%
Stop loss guide
Price Levels
52W High
₹2,537.56
At 52W high
52W Low
₹1,841.96
+26.55% above
From 52W High
-8.14%
NR7
No
Narrow range 7-day
NR4
No
Narrow range 4-day
Price > 20D High
No

30-Day Indicator History

Date Close RSI 1D % Vol × Conditions
02 Oct ₹2,331.00 43.1 +0% 1.6× —
01 Oct ₹2,331.00 43.1 -0.16% 1.7× —
30 Sep ₹2,334.70 43.5 -4.37% 2.3× VOL
29 Sep ₹2,441.50 54.1 +4.98% 2.5× VOL
28 Sep ₹2,325.70 39.1 -2.28% 2.1× VOL
25 Sep ₹2,380.00 45.6 -2.07% 1.7× —
24 Sep ₹2,430.40 53.2 -1.8% 1× —
23 Sep ₹2,475.00 61.8 +0.55% 1.3× —
22 Sep ₹2,461.40 59.9 +0.47% 0.9× —
21 Sep ₹2,450.00 58.4 +0.11% 0.8× —
18 Sep ₹2,447.40 58.1 +1.3% 1.1× —
16 Sep ₹2,410.00 53 +1.61% 1.4× —
14 Sep ₹2,419.20 54.9 +0% 0.7× —
11 Sep ₹2,419.20 54.9 +0.17% 0.7× —
10 Sep ₹2,415.00 54.4 -0.82% 0.5× —
09 Sep ₹2,435.00 57.6 -1.6% 0.8× —
08 Sep ₹2,474.50 64.5 +0.92% 0.8× —
07 Sep ₹2,451.90 62.1 +0.6% 0.5× —
04 Sep ₹2,437.20 60.5 -0.89% 0.8× —
03 Sep ₹2,459.00 64.3 -0.04% 0.9× —
02 Sep ₹2,460.00 64.5 -0.42% 1× —
01 Sep ₹2,470.40 66.2 -0.39% 1.3× —
31 Aug ₹2,480.00 67.7 -1.39% 1.8× —
28 Aug ₹2,515.00 73.6 +2.24% 1.5× RSI>70 BRK
27 Aug ₹2,460.00 69.8 +0.89% 0.9× —
26 Aug ₹2,438.30 68.1 +1.6% 0.9× —
25 Aug ₹2,400.00 64.9 +0.39% 1.3× —
24 Aug ₹2,390.70 64.1 +3.14% 1.4× —
21 Aug ₹2,317.90 56.8 -0.64% 0.5× —
20 Aug ₹2,332.90 59.1 +3.85% 1.1× —

Sector Peers — Healthcare

Symbol Price 1D % RSI Vol × EMA50
FORTIS
Fortis Healthcare
₹785.00 +0% 24.7 3.4× ↓ Below View →
APOLLOHOSP
Apollo Hospitals
₹8,133.50 +0% 29.7 2× ↓ Below View →
METROPOLIS
Metropolis Healthcare
₹537.90 +0% 31.5 1.8× ↓ Below View →
MAXHEALTH
Max Healthcare
₹940.95 +0% 31.3 1.8× ↓ Below View →
KIMS
Krishna Institute of Medical Sciences Ltd.
₹736.25 +0% 34.7 1.6× ↓ Below View →
ZYDUSLIFE
Zydus Lifesciences Ltd.
₹1,145.70 +0% 47.7 1.5× ↑ Above View →
LALPATHLAB
Dr. Lal PathLabs
₹2,005.10 +0% 67.6 1.5× ↑ Above View →
RAINBOW
Rainbow Childrens Medicare Ltd.
₹1,279.80 +0% 20.5 1.5× ↓ Below View →

Want to backtest a strategy on GLENMARK?

Choose from 443 pre-built NSE strategies and see historical results in 60 seconds.

Sign Up Free →
Run Free Backtest Now

We use cookies to keep you signed in and understand how the platform is used. See our Privacy Policy.

Still there?

Here's something you might like

or

One email a week. No spam, unsubscribe anytime.

SEBI Compliance Disclaimer

MomentumIQ is an educational platform for strategy research and backtesting. We do not provide investment advice, recommendations, or tips. All backtest results are hypothetical, based on historical data, and for educational purposes only. Past performance is not indicative of future results. Backtested results may not account for brokerage, slippage, taxes, or other real-world costs. Please consult a SEBI-registered investment advisor before making any investment decisions.